Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
CNOOC
00883
| (Q3)Feb 28, 2026 | (Q2)Nov 30, 2025 | (Q1)Aug 31, 2025 | (FY)May 31, 2025 | (Q4)May 31, 2025 | (Q3)Feb 28, 2025 | (Q2)Nov 30, 2024 | (Q1)Aug 31, 2024 | (FY)May 31, 2024 | (Q4)May 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 58.55%47.69K | -5.90%31.66K | -74.14%6.9K | -6.71%112.73K | -70.65%22.34K | 340.42%30.08K | -15.68%33.64K | 1,086.48%26.67K | 6.12%120.84K | 167.45%76.12K |
| Selling and administrative expenses | 58.55%47.69K | -5.90%31.66K | -74.14%6.9K | -6.71%112.73K | -70.65%22.34K | 340.42%30.08K | -15.68%33.64K | 1,086.48%26.67K | 6.12%120.84K | 167.45%76.12K |
| -General and administrative expense | 58.55%47.69K | -5.90%31.66K | -74.14%6.9K | -6.71%112.73K | -70.65%22.34K | 340.42%30.08K | -15.68%33.64K | 1,086.48%26.67K | 6.12%120.84K | 167.45%76.12K |
| Operating profit | -58.55%-47.69K | 5.90%-31.66K | 74.14%-6.9K | 6.71%-112.73K | 70.65%-22.34K | -340.42%-30.08K | 15.68%-33.64K | -1,086.48%-26.67K | -6.12%-120.84K | -167.45%-76.12K |
| Net non-operating interest income (expenses) | 0.01%-16.7K | 0.00%-16.52K | -14.07%-17.87K | 0.20%-68.42K | -293.91%-17.92K | 12.63%-16.71K | 11.06%-16.52K | 20.51%-15.67K | 0.21%-68.56K | 73.95%-4.55K |
| Non-operating interest expense | ---- | ---- | 14.07%17.87K | -0.20%68.42K | 40.95%6.41K | 13.99%21.79K | 31.87%24.49K | -20.51%15.67K | -0.21%68.56K | -73.95%4.55K |
| Total other finance cost | -0.01%16.7K | 0.00%16.52K | ---- | ---- | ---- | --16.71K | --16.52K | ---- | ---- | ---- |
| Other net income (expenses) | 4.02%45.25K | -0.51%43.5K | 0 | 43.5K | 0.36%43.72K | |||||
| Special income (charges) | --0 | --0 | 4.02%45.25K | -0.51%43.5K | --0 | --0 | --0 | --43.5K | 0.36%43.72K | 4,372,100.00%43.72K |
| -Less:Other special charges | ---- | ---- | -4.02%-45.25K | 0.51%-43.5K | --0 | ---- | ---- | ---43.5K | -0.36%-43.72K | ---- |
| Income before tax | -37.64%-64.4K | 3.96%-48.18K | 1,668.13%20.48K | 5.50%-137.65K | -8.98%-40.26K | -80.30%-46.79K | 14.22%-50.16K | 105.27%1.16K | -4.80%-145.67K | 19.56%-36.94K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | -37.64%-64.4K | 3.96%-48.18K | 1,668.13%20.48K | 5.50%-137.65K | -8.98%-40.26K | -80.30%-46.79K | 14.22%-50.16K | 105.27%1.16K | -4.80%-145.67K | 19.56%-36.94K |
| Net income continuous operations | -37.64%-64.4K | 3.96%-48.18K | 1,668.13%20.48K | 5.50%-137.65K | -8.98%-40.26K | -80.30%-46.79K | 14.22%-50.16K | 105.27%1.16K | -4.80%-145.67K | 19.56%-36.94K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -37.64%-64.4K | 3.96%-48.18K | 1,668.13%20.48K | 5.50%-137.65K | -8.98%-40.26K | -80.30%-46.79K | 14.22%-50.16K | 105.27%1.16K | -4.80%-145.67K | 19.56%-36.94K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -37.64%-64.4K | 3.96%-48.18K | 1,668.13%20.48K | 5.50%-137.65K | -8.98%-40.26K | -80.30%-46.79K | 14.22%-50.16K | 105.27%1.16K | -4.80%-145.67K | 19.56%-36.94K |
| Diluted earnings per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic earnings per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.